An estimated 20–25% of the population is affected by chronic, non-communicable
inflammatory skin diseases. Chronic skin inflammation has many causes. Among the most …

Bullous pemphigoid is the most frequent autoimmune bullous disease and mainly affects
elderly individuals. Increase in incidence rates in the past decades has been attributed to …

Background Bullous pemphigoid (BP) is the most common autoimmune subepidermal
bullous disease of the skin. First-line treatment of systemic corticosteroids may cause …

Bullous pemphigoid (BP) is the most common autoimmune subepidermal blistering disease
in Western countries, and typically affects the elderly. BP is immunologically characterized …

Urticaria is a common, mast cell-driven disease presenting with wheals or angioedema or
both. In the last years, urticaria has increasingly attracted notice to clinicians and …

Background Bullous pemphigoid is a blistering skin disorder with increased mortality. We
tested whether a strategy of starting treatment with doxycycline gives acceptable short-term …

Autoimmune bullous disorders are a heterogeneous spectrum of skin disorders
characterized by the production of autoantibodies against adhesion molecules of the skin …

Bullous pemphigoid (BP) is the most common autoimmune bullous disorder which is
characterized by autoantibodies against hemidesmosomal proteins of the skin and mucous …

Background Case reports have suggested an association between dipeptidyl peptidase-4
inhibitors (DPP4is) and development of bullous pemphigoid (BP). Objective To evaluate the …

This guideline on mucous membrane pemphigoid (MMP) has been elaborated by the Task
Force for Autoimmune Blistering Diseases of the European Academy of Dermatology and …